Jeffrey M Cochran
Overview
Explore the profile of Jeffrey M Cochran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cochran J
JMIR Ment Health
. 2024 Dec;
11:e62959.
PMID: 39727095
Background: Sleep-wake patterns are important behavioral biomarkers for patients with serious mental illness (SMI), providing insight into their well-being. The gold standard for monitoring sleep is polysomnography (PSG), which requires...
2.
Jan M, Coppin-Renz A, West R, Gallo C, Cochran J, Heumen E, et al.
JMIR Form Res
. 2023 Dec;
7:e44768.
PMID: 38085556
Background: Wearable sensors in digital health may pose a risk for skin irritation through the use of wearable patches. Little is known about how patient- and product-related factors impact the...
3.
Chopra A, Boskovic D, Kulkarni A, Cochran J
Clinicoecon Outcomes Res
. 2023 May;
15:375-386.
PMID: 37252199
Objective: Strategies designed to track drug ingestion may improve medication adherence and clinical outcomes in adults with schizophrenia. This study aimed to estimate the cost-effectiveness of aripiprazole tablets with sensor...
4.
Wang L, Cochran J, Ko T, Baker W, Abramson K, He L, et al.
Nat Biomed Eng
. 2022 Aug;
6(9):1017-1030.
PMID: 35970929
Direct assessment of blood oxygenation in the human placenta can provide information about placental function. However, the monitoring of placental oxygenation involves invasive sampling or imaging techniques that are poorly...
5.
Cochran J, Fang H, Sonnenberg J, Cohen E, Lindenmayer J, Reuteman-Fowler J
Neuropsychiatr Dis Treat
. 2022 Aug;
18:1521-1534.
PMID: 35928793
Purpose: Schizophrenia is a severe, chronic condition accounting for disproportionate healthcare utilization. Antipsychotics can reduce relapse rates, but the characteristics of schizophrenia may hinder medication adherence. A phase 3b open-label...
6.
Cochran J, Fang H, Gallo C, Peters-Strickland T, Lindenmayer J, Reuteman-Fowler J
Patient Prefer Adherence
. 2022 Aug;
16:1805-1817.
PMID: 35923658
Purpose: A recent, phase 3b, mirror-image clinical trial of outpatients with schizophrenia found that use of aripiprazole tablets with sensor (AS; Abilify MyCite, comprising an ingestible event-marker sensor embedded in...
7.
Rubtsova N, Hart M, Arroyo A, Osharovich S, Liebov B, Miller J, et al.
Bioconjug Chem
. 2021 Jun;
32(8):1852-1863.
PMID: 34139845
New exogenous probes are needed for both imaging diagnostics and therapeutics. Here, we introduce a novel nanocomposite near-infrared (NIR) fluorescent imaging probe and test its potency as a photosensitizing agent...
8.
Cochran J, Heidary Z, Knights J
NPJ Digit Med
. 2021 Apr;
4(1):63.
PMID: 33824406
Activity patterns can be important indicators in patients with serious mental illness. Here, we utilized an accelerometer and electrocardiogram incorporated within a digital medicine system, which also provides objective medication...
9.
Heidary Z, Cochran J, Peters-Strickland T, Knights J
JMIR Form Res
. 2021 Mar;
5(3):e17993.
PMID: 33650981
Background: Adherence to medication regimens and patient rest are two important factors in the well-being of patients with serious mental illness. Both of these behaviors are traditionally difficult to record...
10.
Cochran J, Leproux A, Busch D, OSullivan T, Yang W, Mehta R, et al.
J Biomed Opt
. 2021 Feb;
26(2).
PMID: 33624457
Significance: Current imaging paradigms for differential diagnosis of suspicious breast lesions suffer from high false positive rates that force patients to undergo unnecessary biopsies. Diffuse optical spectroscopic imaging (DOSI) noninvasively...